Cargando…
T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice
Nonresolving inflammation is involved in the initiation and progression process of tumorigenesis. Src homology 2 domain-containing tyrosine phosphatase 2 (SHP2) is known to inhibit acute inflammation but its role in chronic inflammation-associated cancer remains unclear. The role of SHP2 in T cells...
Autores principales: | Liu, Wen, Guo, Wenjie, Shen, Lihong, Chen, Zhen, Luo, Qiong, Luo, Xiaolin, Feng, GenSheng, Shu, Yongqian, Gu, Yanhong, Xu, Qiang, Sun, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352345/ https://www.ncbi.nlm.nih.gov/pubmed/27935860 http://dx.doi.org/10.18632/oncotarget.13812 |
Ejemplares similares
-
Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis
por: Guo, Wenjie, et al.
Publicado: (2017) -
SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
por: Zhao, Mingxia, et al.
Publicado: (2019) -
Loss of SHP-2 activity in CD4(+) T cells promotes melanoma progression and metastasis
por: Zhang, Tao, et al.
Publicado: (2013) -
Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations
por: Bauler, Timothy J., et al.
Publicado: (2011) -
SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development
por: Gagné-Sansfaçon, Jessica, et al.
Publicado: (2016)